Lonza to Divest Peptides Business to PolyPeptide

Lonza (Switzerland) and the PolyPeptide Group (Belgium) jointly announced that PolyPeptide Laboratories Holding (PPL) AB has entered into a definitive agreement with Lonza Sales AG and Lonza AG (both 100 percent affiliates of Lonza Group AG) to acquire the peptides business and operations of Lonza in Braine-l’Alleud, Belgium. Lonza’s Braine facility, with approximately 280 employees, ...